You have 9 free searches left this month | for more free features.

Lymphoma, Non-Hodgkin

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lymphoma, Non-Hodgkin Lymphoma, B-Cell Trial (BAFF CAR-T)

Not yet recruiting
  • Lymphoma, Non-Hodgkin Lymphoma, B-Cell
  • BAFF CAR-T
  • (no location specified)
Aug 16, 2022

Lymphoma, Non-Hodgkin, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in New York (Venetoclax, Tazemetostat)

Not yet recruiting
  • Lymphoma, Non-Hodgkin
  • +2 more
  • New York, New York
    Weill Cornell Medicine/NewYork-Presberteryian Hospital
Jan 18, 2023

Living Conditions After Non-Hodgkin's Lymphoma in France

Not yet recruiting
  • Non-hodgkin's Lymphoma
  • Data collection
  • Questionnaires
  • Dijon, France
    Chu Dijon Bourgogne
Oct 13, 2022

B-cell Non-Hodgkin's Lymphoma Trial (IMM0306, Lenalidomide capsule)

Not yet recruiting
  • B-cell Non-Hodgkin's Lymphoma
  • (no location specified)
Mar 6, 2023

Immunogenicity of COVID-19 Vaccinations in Autologous HSCT

Not yet recruiting
  • COVID-19
  • +2 more
    • Cologne, NRW, Germany
      University Hospital of Cologne
    Oct 27, 2022

    Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Non Hodgkin Lymphoma Trial in Jinan (CAR-T cells)

    Recruiting
    • Relapsed Non-Hodgkin Lymphoma
    • +2 more
    • CAR-T cells
    • Jinan, Shandong, China
      The Second People's Hospital of Shandong Province
    Jun 14, 2022

    Lymphoma, Non-Hodgkin, Relapsed Non Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma Trial in United States (CB-010,

    Recruiting
    • Lymphoma, Non-Hodgkin
    • +6 more
    • CB-010
    • +2 more
    • Scottsdale, Arizona
    • +7 more
    Aug 19, 2022

    Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory, Advanced Solid Tumor Trial (TR115)

    Not yet recruiting
    • Non-Hodgkin's Lymphoma, Relapsed
    • +2 more
    • (no location specified)
    Dec 6, 2022

    Relapsed or Refractory B Cell Non-Hodgkin Lymphoma Trial (C-CAR066)

    Not yet recruiting
    • Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
    • (no location specified)
    Mar 23, 2023

    DLBCL - Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Follicular Lymphoma Trial (Bridging radiation therapy,

    Not yet recruiting
    • DLBCL - Diffuse Large B Cell Lymphoma
    • +6 more
    • Bridging radiation therapy
    • +2 more
    • (no location specified)
    Jan 4, 2023

    Advanced or Metastatic Solid Tumors, Non-Hodgkin Lymphoma Trial in San Antonio (WTX-330)

    Recruiting
    • Advanced or Metastatic Solid Tumors
    • Non-Hodgkin Lymphoma
    • San Antonio, Texas
      NEXT Oncology
    Jan 6, 2023

    Relapsed Non Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma Trial in Cleveland (Loncastuximab tesirine, Venetoclax)

    Recruiting
    • Relapsed Non Hodgkin Lymphoma
    • Refractory Non-Hodgkin Lymphoma
    • Cleveland, Ohio
      Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cance
    May 20, 2022

    Lymphoma, Lymphoma, B-Cell, Lymphoma, T-Cell Trial in New York (Pharmacokinetics)

    Recruiting
    • Lymphoma
    • +4 more
    • Pharmacokinetics
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Sep 12, 2022

    B-cell Non Hodgkin Lymphoma Trial in Hanzhou (CB dualCAR-NK19/70)

    Not yet recruiting
    • B-cell Non Hodgkin Lymphoma
    • CB dualCAR-NK19/70
    • Hanzhou, Zhejiang, China
      2nd Affiliated Hospital, School of Medicine, Zhejiang University
    Dec 25, 2022

    B-cell Non-Hodgkin Lymphoma (B-NHL) Trial in Austin (UCART20x22, CLLS52)

    Recruiting
    • B-cell Non-Hodgkin Lymphoma (B-NHL)
    • UCART20x22
    • CLLS52
    • Austin, Texas
      Sarah Cannon - St. David South Austin Medical Center
    Dec 8, 2022

    Non Hodgkin Lymphoma Trial in Cologne, Essen (CTL019)

    Active, not recruiting
    • Non Hodgkin Lymphoma
    • Cologne, Germany
    • +1 more
    Mar 2, 2022

    Lymphoma, Non-Hodgkin Trial in Saint Louis (Stem cell infusion, TLI, Anti-thymocyte globulin)

    Active, not recruiting
    • Lymphoma, Non-Hodgkin
    • Stem cell infusion
    • +5 more
    • Saint Louis, Missouri
      Washington University
    Jan 12, 2022

    Mature B-Cell Non-Hodgkin Lymphoma Trial (Obinutuzumab, Glofitamab, Rituximab)

    Not yet recruiting
    • Mature B-Cell Non-Hodgkin Lymphoma
    • (no location specified)
    Sep 6, 2022

    B-cell Malignancy, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (AS-1763)

    Not yet recruiting
    • B-cell Malignancy
    • +7 more
    • (no location specified)
    Oct 26, 2022

    Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma Trial in Beijing (JS203 for Injection)

    Not yet recruiting
    • Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
    • JS203 for Injection
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Nov 11, 2022

    B-cell Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (IKS03)

    Not yet recruiting
    • B-cell Non-Hodgkin Lymphoma
    • +4 more
    • (no location specified)
    May 6, 2022

    Non-Hodgkin's Lymphoma Trial in Vitoria-Gasteiz (RiTUXimab Injection [Truxima])

    Recruiting
    • Non-Hodgkin's Lymphoma
    • RiTUXimab Injection [Truxima]
    • Vitoria-Gasteiz, Alava, Spain
      Hospital Universitario Araba- Sede Txagorritxu
    Mar 30, 2022

    Non-hodgkin Lymphoma, Hodgkin Lymphoma, Lymphoma Trial in Chicago (Radiation - Dose Level 0, Radiation - Dose Level 1, Radiation

    Recruiting
    • Non-hodgkin Lymphoma
    • +2 more
    • Radiation - Dose Level 0
    • +4 more
    • Chicago, Illinois
      University of Chicago
    Dec 3, 2021

    Young Adults, Lymphoma, Non-Hodgkin, Hodgkin Disease Trial in Clermont-Ferrand (Indirect calorimetric test during submaximal

    Recruiting
    • Young Adults
    • +2 more
    • Indirect calorimetric test during submaximal exercise
    • Clermont-Ferrand, France
      CHU de Clermont-Ferrand
    May 3, 2022

    NonHodgkin's Lymphoma Refractory Trial in El Segundo (N803, CD19t-haNK suspension, Cyclophosphamide)

    Not yet recruiting
    • NonHodgkin's Lymphoma Refractory
    • El Segundo, California
      CSSIFM
    Nov 9, 2022